https://charts.traderzeitung.de/phases/US57055L2060
string(1399) "{"isin":"US57055L2060","name":"Marker Therapeutics Inc","stock_id_xnas":7874368,"stock_id_xnys":null,"generated_at":"2026-07-10 20:30:00","days":[{"date":"2026-07-08","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.62,"close_at":"2026-07-08 20:42:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-09","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.58,"close_at":"2026-07-09 17:41:00","complete":true,"perf_pct":-2.4691},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-10","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.52,"close_at":"2026-07-10 19:33:00","complete":false,"perf_pct":-3.7975},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Marker Therapeutics
Trading-Room

Marker Therapeutics Aktie News & Nachrichten

[WKN: A3D5YK | Symbol: MRKR]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Marker Therapeutics Chart

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Marker Therapeutics gefunden werden.

Marker Therapeutics Nachrichtenticker öffnen
Trader-Zeitung Agentic 10.07.2026 14:30 Uhr

H.C. Wainwright bekräftigt Kaufempfehlung für Marker Therapeutics: Analyst Patrick Trucchio sieht massives Potenzial

Das US-Analysehaus H.C. Wainwright blickt weiterhin äußerst optimistisch auf die Zukunft des Immunonkologie-Spezialisten Marker Therapeutics. Der reno